Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Martin Møller

Martin Møller has broad and deep experience in the international healthcare industry from more than 20 years at McKinsey & Company, a global management consultancy, where he was a leader in the Pharmaceuticals & Medical Products Practice until 2021. In that role, he advised companies on strategy, transformation and business development, as well as product development, launch and commercialization. Martin Møller has worked with many segments of the life science industry and across geographies. His experience includes both working with companies in the rapid growth phase and more established companies with global operations. Today he is a professional board member. Martin’s university degree is in the humanities. He is a citizen of Denmark and the US. 

Current assignments: Chair of the Board of Scandion Oncology A/S. Chair of the Board of Re-Zip ApS. Board member of Rehaler A/S. 

Previous assignments (last five years): Senior Partner, McKinsey & Company. Chair of McKinsey & Company Denmark P/S. Board member of Edvince AB. 

Amount of shares in Immunovia: 2 464